Biogen Inc.’s new at-home Alzheimer’s drug will give the company an edge over rival Eli Lilly Co.’s competing therapy, its chief executive officer said in an interview.

Preliminary total global full year 2025 revenue of approximately $616 millionPreliminary BRIUMVI U.S. fourth quarter and full year 2025 net ...

When you get IV vitamin infusions outside of a medical setting, it’s difficult to know what’s going into your body and how it ...

ESTEVE and TerSera Therapeutics LLC announced today that they have entered into an agreement in which ESTEVE will acquire ...

BIRMINGHAM, Ala. ( WBRC) - Alabama Attorney General Steve Marshall has announced that the state settled a lawsuit with a ...

The "Ypsomed Holding AG (YPSN) - Product Pipeline Analysis, 2025 Update" company profile has been added to ResearchAndMarkets.com's offering.

I don’t know about you, but I’ve always preferred making my own antibodies. Why outsource it? It’s so handy letting my own body do the work of fighting infections while I’m writing articles or ...

Even as OpenAI works to harden its Atlas AI browser against cyberattacks, the company admits that prompt injections, a type of attack that manipulates AI agents to follow malicious instructions often ...

GLP 1 medicines like semaglutide and liraglutide, plus the newer dual agonist tirzepatide, have changed obesity and type 2 diabetes care. They also come with side effects, and every so often, with ...

A close-up photo of Karoline Leavitt from Vanity Fair’s stunning pieces about White House officials got a lot of attention this week for revealing what appear to be familiar dots around the press ...